T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity

被引:28
作者
Ichiki, Y
He, XS
Shimoda, S
Ishibashi, H
Keeffe, EB
Rossaro, L
Gershwin, ME
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[3] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki 8568562, Japan
[4] Stanford Univ, Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[5] Univ Calif Davis, Transplant Med Housestaff FAC, Sacramento, CA 95817 USA
关键词
D O I
10.1016/j.autrev.2004.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells are involved in the pathogenesis of important liver diseases including both autoimmune liver diseases, and viral hepatitis. In addition to playing a crucial role in the control of hepatitis viruses, T cell responses are also responsible for the liver injury during acute and chronic phases of viral hepatitis. In this article, we reviewed current literature on T cell immunity to hepatitis B and C viruses. In addition, antigen presenting cells that are critical for T cell immunity against these viruses are also discussed. This will provide insights to the understanding of T cell immunity in autoimmune liver diseases due to the similar role of T cells in autoimmune liver diseases and viral hepatitis. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:82 / 95
页数:14
相关论文
共 88 条
[81]   Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C [J].
Ulsenheimer, A ;
Gerlach, JT ;
Gruener, NH ;
Jung, MC ;
Schirren, CA ;
Schraut, W ;
Zachoval, R ;
Pape, GR ;
Diepolder, HM .
HEPATOLOGY, 2003, 37 (05) :1189-1198
[82]   Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C [J].
Urbani, S ;
Boni, C ;
Missale, G ;
Elia, G ;
Cavallo, C ;
Massari, M ;
Raimondo, G ;
Ferrari, C .
JOURNAL OF VIROLOGY, 2002, 76 (24) :12423-12434
[83]   Cellular immune responses against hepatitis C virus: the evidence base 2002 [J].
Ward, S ;
Lauer, G ;
Isba, R ;
Walker, B ;
Klenerman, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (02) :195-203
[84]   Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection [J].
Webster, G ;
Bertoletti, A .
MOLECULAR IMMUNOLOGY, 2001, 38 (06) :467-473
[85]   Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms [J].
Webster, GJM ;
Reignat, S ;
Maini, MK ;
Whalley, SA ;
Ogg, GS ;
King, A ;
Brown, D ;
Amlot, PL ;
Williams, R ;
Vergani, D ;
Dusheiko, GM ;
Bertoletti, A .
HEPATOLOGY, 2000, 32 (05) :1117-1124
[86]   Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection [J].
Wedemeyer, H ;
He, XS ;
Nascimbeni, M ;
Davis, AR ;
Greenberg, HB ;
Hoofnagle, JH ;
Liang, TJ ;
Alter, H ;
Rehermann, B .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3447-3458
[87]  
Wong DKH, 1998, J IMMUNOL, V160, P1479
[88]   Bone marrow NK1.1- and NK1.1+ T cells reciprocally regulate acute graft versus host disease [J].
Zeng, DF ;
Lewis, D ;
Dejbakhsh-Jones, S ;
Lan, FS ;
García-Ojeda, M ;
Sibley, R ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1073-1081